A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for the Treatment of Vocal Fold Scarring and Age-Related Dysphonia

Trial Profile

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Azficel-T for the Treatment of Vocal Fold Scarring and Age-Related Dysphonia

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Feb 2017

At a glance

  • Drugs Azficel-T (Primary)
  • Indications Dysphonia
  • Focus Therapeutic Use
  • Sponsors Fibrocell Science
  • Most Recent Events

    • 30 Jan 2017 Status changed from active, no longer recruiting to completed.
    • 07 Jul 2016 Planned End Date changed from 1 Jun 2016 to 1 Apr 2017.
    • 08 Jun 2016 Primary endpoint (Voice parameters) has not been met, according to Fibrocell Science media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top